What Do Analysts Say About Keryx Biopharmaceuticals Inc. (KERX)

If you are investing like Buffett, the report can assist in finding the company with the durable competitive advantage, and if Peter Lynch is your hero, you might find a low P/E ratio, share buyback or future earnings growth in the depths of the report. The consensus recommendation by Thomson Reuters analysts is Outperform and their mean rating for the stock is 1.77 on scale of 1-5.

While looking at the Stock's Performance, Keryx Biopharmaceuticals Inc. now shows a Weekly Performance of 13.13%, where Monthly Performance is 23.82%, Quarterly performance is 8.45%, 6 Months performance is 33.83% and yearly performance percentage is 33.83%. (KERX) for the current quarter. 9 analysts projected on average Earnings.

For the next year first quarter, analysts predicted EPS estimates trend of $0.58 which would leave an impact on the stock performance in coming months. The firm earned $9.53 million during the quarter, compared to the consensus estimate of $9.65 million. The High end of the Estimate is $10.7 Million, while the Low end of the Estimate is $9.75 Million. The company had Year Ago Sales of $15.2 Million. Price targets frequently change, depending on the outlook for a company's earnings.

The 8 analysts offering 12-month price forecasts for Keryx Biopharmaceuticals Inc have a median target of 6.50, with a high estimate of 10.00 and a low estimate of 4.00. Over the last 90 days, insiders sold 38,208 shares of company stock valued at $183,508.

The Stock now has the market capitalization of $611.57 Million, P/E (price to earnings ttm) of 0 and Weekly volatility of 7.89% and monthly volatility of 6.36% respectively. Rice Hall James & Associates LLC now owns 1,325,917 shares of the biopharmaceutical company's stock worth $7,041,000 after buying an additional 413,087 shares during the period. The company has a 50-day moving average of $5.29 and a 200 day moving average of $5.36.

Keryx Biopharmaceuticals Inc. (KERX) topped its 52-week high price target of 7.8 on Jul 20, 2016. Corporate insiders own 3.08% of the company's stock.

The firm has noticeable returns on equity ratio of -141.70%, which shows how much profit each dollar of ordinary stockholders' equity generates.

Keryx Biopharmaceuticals, Inc.'s (KERX) witnessed a gain of 7.89% in recent trading period with closing price of $ 6.29. The company's Relative strength index is 54.79. The stock got a shaky start early morning on analyst's remarks. (IMMU) as "STRONG BUY", 0 rated as "BUY" and 1 issued a "HOLD" rating. Here, 1 indicates a Strong Buy and 5 indicates a Strong Sell. The highest and lowest price target given by the brokerage firms to the equity are $7.5 and $7.5, respectively.

Separately, Citigroup Inc raised Keryx Biopharmaceuticals from a sell rating to a neutral rating and set a $7.00 target price on the stock in a research note on Wednesday, January 11th.

The stock is now trading at a distance of 14.81% from SMA-20. Maxim Group's target price suggests a potential upside of 23.24% from the stock's current price. Marco Investment Management LLC now owns 49,350 shares of the biopharmaceutical company's stock worth $262,000 after buying an additional 3,000 shares in the last quarter. The biopharmaceutical company reported ($0.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by $0.07. The stock stands almost -25.46% off versus the 52-week high and 90.28% away from the 52-week low.

Recommended News

  • The Witcher 4 Report Debunked: It's A Very Old Statement

    The Witcher 4 Report Debunked: It's A Very Old Statement

    The last of the series was critically acclaimed for its depth and story and was considered as one of the best RPGs off all time. In fact, then upcoming game may even be a bigger success than " The Witcher 3: Wild Hunt ", according to its co-founder.

    Why to Keeping Eye on Lockheed Martin Corporation (LMT), Comerica Incorporated (CMA)?

    In ratings table the TEX given BUY ratings by 8 analysts in current phase and 1 analyst suggest it as overweight security. The stock is going forward its fifty-two week low with 28.73% and lagging behind from its 52-week high price with 0.48%.

    Unusual Volume Spikes For: Precision Drilling Corporation (NYSE:PDS)

    The share price has moved backward from its 20 days moving average -11.72% and negatively from its 50 days moving average -15.56%. Precision Drilling Corporation's (PDS ) witnessed a gain of 0.60% in recent trading period with closing price of $ 5.06.
  • Real estate worth $121 billion to benefit from REIT opportunity in India

    The Company's business consists of the ownership and operation of real property in the greater Washington metro region. The 52 week high of Real Estate Investors PLC's shares is 64.9 whilst the 52 week low for shares in the company is 50.

    Latest Analysts Score of Stock: New York Community Bancorp Inc. (NYCB)

    Maximum and minimum EPS estimate for the current quarter is projected at $0.24 and $0.22, respectively, according to 13 analysts. The Return on Equity (ROE) value stands at 8.1%. (NYCB) traded with the volume of 6.76 Million in the previous trading session.
    Hibbing JC Penney store to close

    Hibbing JC Penney store to close

    Sears closed at Eastridge in late 2014, one of about 100 stores the struggling retailer said it was closing at the time. Ellison told USA Today that by closing 138 stores , the retail chain will aim to raise the standard of its brand name.
  • Park Hotels & Resorts Inc (PK) To Go Ex-Dividend on March 29th

    Comparatively, Host Hotels & Resorts, Inc. posted earnings of $0.39 per share in the same quarter a year ago . (HST) is at 46.48. Sarasin & Partners LLP boosted its stake in shares of Host Hotels and Resorts by 1.1% in the third quarter.

    Phil Spencer Teases Popular Game Will Soon Be Xbox One Backwards Compatible

    Spencer responded by saying that Xbox usage for buying games and DLCs are high, while the console's attach rate is also high. Call of Duty: Black Ops 2 is the most requested game, although it sounds like it won't be on the list yet.
    One Stock Analysts Are Watching - Sirius XM Holdings Inc. (NASDAQ:SIRI)

    One Stock Analysts Are Watching - Sirius XM Holdings Inc. (NASDAQ:SIRI)

    For SIRI, the company now has $213.94 Million of cash on the books, which is offset by $5.49 Million current liabilities. Biegel & Waller LLC acquired a new position in Sirius XM Holdings during the fourth quarter valued at $101,000.
  • Next Weeks Broker Price Targets For Concordia Healthcare Corp. (NASDAQ:CXRX)

    Next Weeks Broker Price Targets For Concordia Healthcare Corp. (NASDAQ:CXRX)

    Concordia International Corp has a 52 week low of $1.69 and a 52 week high of $34.52 The company's market cap is now $0. A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company.

    Lockheed Martin moving F-16 production to SC

    Erickson said Lockheed's Greenville complex could wind up making more F-16s than just the 19 proposed to be sold to Bahrain. News media outlets report the company is moving production of the warplane nicknamed the Fighting Falcon to Greenville.
    Charlotte Crosby Opens Up About Her Rare Breast Condition, 'Uniboob'

    Charlotte Crosby Opens Up About Her Rare Breast Condition, 'Uniboob'

    To make matters worse the reality star wasn't alone in bed and her boyfriend, Stephen Bear also had to deal with Char's accident. Charlotte and Bear are now on holiday together - and have discussed their plans to marry and start a family in recent weeks.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.